Recent Posts
- Reading the Effect of Tea Leaves…and Beating Genetic Fatalism in Breast Cancer
- Tet1 Enzyme Based Enrichment Method for Methylome Sequencing: TamC-Seq
- Introducing Aba-seq for Enzyme Based High-Res Mapping of Mammalian Hydroxymethylomes
- Methylome Data in Lethal Prostate Cancer Supports Personalized Medicine
- New Years Resolution, Reflection on Cancer Research
Recent Comments
- Bill Graham on Sirtuin3 Reprograms Mitochondrial Epigenetic Pathways: How Diet Affects Age
- Doug on Will the Long History of Breast Cancer Research Culminate with Epigenetics Based Personalized Medicine?
- Canada Joins the International Human Epigenome Consortium – Q&A with Tomi Pastinen of Génome Québec | Epigenetics Experts Blog on Q&A with BLUEPRINT’s Henk Stunnenberg on the New Leukemia, Blood Epigenome Project
- Doug on Oxidative Bisulfite Sequencing (oxBS-Seq) A Brilliant Advance for Epigenetics
- The Epigenetics of Real-Life Stress and Serotonin | Epigenetics Experts Blog on Situational Stress Makes Short-Term Epigenetic Changes
Archives
- June 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
Categories
- Applications (74)
- Animal Models (8)
- Cell Culture Models (3)
- chIP (7)
- Clinical Studies (7)
- Conformation Capture (2)
- DNA Extraction / Purification (2)
- Flow Cytometry (4)
- Gene Silencing (8)
- siRNA (4)
- Genomewide Methylation Profiling (24)
- Histone Modification Assay (1)
- Imaging (5)
- Mass Spec (5)
- Methyl-specific Antibodies (3)
- Methylated DNA Capture (4)
- Methylation Sensitive Restriction Enzymes (1)
- Methylation Specific PCR (2)
- Methyltransferases (6)
- Next Gen Sequencing (14)
- Real-time PCR (3)
- Sodium Bisulfite Sequencing (9)
- Transcriptome microarray (5)
- Twin studies (1)
- Behavioral Epigenetics (4)
- Bioinformatics (11)
- Biomarkers (19)
- Cellular Biology (9)
- Chromatin Structure (8)
- Chromosome conformation capture (1)
- Cistrome (1)
- Conferences (3)
- Developmental Biology (11)
- Divergent Transcription (5)
- DNA Methylation (50)
- Enzymology (13)
- Acetylation (4)
- Glycosylases (1)
- Methylation (5)
- Methyltransferases (4)
- Phosphorylation (1)
- Ubiquitination (2)
- Epigenome (4)
- Evolutionary Epigenetics (6)
- Forensic genetics (1)
- Gene Regulation (19)
- Genetics (7)
- Hematology (1)
- Histone Modifications (15)
- Histones (5)
- History & Trends (13)
- Hydroxymethylation (5)
- Immunology (6)
- Metabolism (3)
- Microarray (4)
- Microbial Epigenetics (5)
- Neuroscience (10)
- Autism (5)
- New Lab Methods (12)
- Non-coding RNA (8)
- microRNA (6)
- Nutrigenomics (4)
- O-GlcNAcylation (1)
- Oncology (23)
- Breast cancer (3)
- Leukemia (6)
- Oncogenes (2)
- Pathology (3)
- Pharmacogenomics (1)
- Pharmacology / Toxicology (2)
- Plant Epigenetics (3)
- Regenerative Medicine (4)
- Reproductive Biology (1)
- Stem Cells (7)
- Transcriptome (6)
- Translational Research (12)
- Diagnostics (6)
- Personalized Medicine (4)
- Uncategorized (1)
- Virology (4)
- Applications (74)
Category Archives: Methyltransferases
The recent news about Angelina Jolie getting a prophylactic double mastectomy is both sad and encouraging. Women, and their physicians, are becoming more aware of individual breast cancer risk. They are willing to use any available treatments to reduce that risk, and promote health. Tamoxifen is a breast cancer drug success story. It works by competing with estradiol for estrogen receptor protein. Thereby inhibiting the Erα (estrogen receptor). See http://www.drugs.com/pro/tamoxifen.html Tamoxifen 1st significantly improves survival. 2nd reduces recurrence. 3rd reduces the incidence of breast cancer in high risk women. The drawback is that the tumors need to be overexpressing estrogen receptor, or ER+. Cancer that is “estrogen receptor negative”, or ER- now has a comparably worse prognosis. This is because … Continue reading
Keeping honeybees runs in our family. My wife’s father keeps many hives, his father kept hives, his father and so on. Our one hive this year produced over 30 pound of honey. Fresh honey is a real treat as the flavor stems from the local fauna: purple loosestrife and apple blossoms. Very different from what you get from the local food mart. Aside from the obvious agricultural benefit that honeybee provides, pollination of plants in the food chain, they are really fascinating insects to observe. Every other year on average in the spring time when the weather is warm and the sky is clear, we can hear a district loud buzzing sound from the hive. A mass exodus of bees … Continue reading
Posted in Animal Models, DNA Methylation, Methyltransferases, Nutrigenomics
Tagged Bees, Epigenetics, methylation, NEB, Royalactin
3 Comments
Here’s an epigenetics first. It turns out that intermolecular signaling in epigenetics — all that ubiquination, methylation, and so forth — doesn’t always end at DNA or histones, where those two components go on just to regulate genes (or to encourage more modification of themselves and each other). Nope, John Latham and colleagues at the University of Texas M.D. Anderson Cancer Center reported in Cell last week that there’s at least one case — in yeast — in which a modified histone allows a non-histone protein to methylate another non-histone protein. That is, the signal travels from the Paf1 complex, to histone H2BK123 by ubiquination, to the COMPASS complex — which needs that ubiquination to di-methylate Dam1. (It’s far more … Continue reading
Last week’s excitement about the discovery of “seventh” and “eighth” DNA bases might’ve obscured parts of that work that shed a little more light on a very murky corner of epigenetics’ cytosine modifications — “Where do the methyls go?” And related research also published last week gets a bit closer to answering, “What does 5-hydroxymethyl-C really do, anyway?” The first, a Science paper by Yi Zhang and his group at the University of North Carolina, does introduce two new cytosine modifications, 5-formylcytosine and 5-carboxylcytosine. But more interesting, I think, is that the group gets halfway through proving a plausible mechanism for cytosine demethylation, which no one’s demonstrated yet. And during the same week, researchers at UCLA and New England Biolabs … Continue reading
